↓ Skip to main content

The use of retroviral vectors for gene therapy-what are the risks? A review of retroviral pathogenesis and its relevance to retroviral vector-mediated gene delivery

Overview of attention for article published in Genetic Vaccines and Therapy, August 2004
Altmetric Badge

About this Attention Score

  • In the top 25% of all research outputs scored by Altmetric
  • High Attention Score compared to outputs of the same age (97th percentile)

Mentioned by

news
1 news outlet
blogs
1 blog
twitter
7 X users
facebook
1 Facebook page

Citations

dimensions_citation
112 Dimensions

Readers on

mendeley
304 Mendeley
You are seeing a free-to-access but limited selection of the activity Altmetric has collected about this research output. Click here to find out more.
Title
The use of retroviral vectors for gene therapy-what are the risks? A review of retroviral pathogenesis and its relevance to retroviral vector-mediated gene delivery
Published in
Genetic Vaccines and Therapy, August 2004
DOI 10.1186/1479-0556-2-9
Pubmed ID
Authors

Donald S Anson

X Demographics

X Demographics

The data shown below were collected from the profiles of 7 X users who shared this research output. Click here to find out more about how the information was compiled.
Mendeley readers

Mendeley readers

The data shown below were compiled from readership statistics for 304 Mendeley readers of this research output. Click here to see the associated Mendeley record.

Geographical breakdown

Country Count As %
Germany 1 <1%
Indonesia 1 <1%
Gambia 1 <1%
Brazil 1 <1%
United States 1 <1%
Unknown 299 98%

Demographic breakdown

Readers by professional status Count As %
Student > Bachelor 56 18%
Student > Master 50 16%
Student > Ph. D. Student 41 13%
Researcher 31 10%
Student > Postgraduate 18 6%
Other 41 13%
Unknown 67 22%
Readers by discipline Count As %
Biochemistry, Genetics and Molecular Biology 63 21%
Agricultural and Biological Sciences 58 19%
Medicine and Dentistry 42 14%
Immunology and Microbiology 12 4%
Engineering 12 4%
Other 43 14%
Unknown 74 24%
Attention Score in Context

Attention Score in Context

This research output has an Altmetric Attention Score of 26. This is our high-level measure of the quality and quantity of online attention that it has received. This Attention Score, as well as the ranking and number of research outputs shown below, was calculated when the research output was last mentioned on 16 April 2024.
All research outputs
#1,493,941
of 25,734,859 outputs
Outputs from Genetic Vaccines and Therapy
#1
of 45 outputs
Outputs of similar age
#1,672
of 66,070 outputs
Outputs of similar age from Genetic Vaccines and Therapy
#1
of 4 outputs
Altmetric has tracked 25,734,859 research outputs across all sources so far. Compared to these this one has done particularly well and is in the 94th percentile: it's in the top 10% of all research outputs ever tracked by Altmetric.
So far Altmetric has tracked 45 research outputs from this source. They receive a mean Attention Score of 4.8. This one scored the same or higher as 44 of them.
Older research outputs will score higher simply because they've had more time to accumulate mentions. To account for age we can compare this Altmetric Attention Score to the 66,070 tracked outputs that were published within six weeks on either side of this one in any source. This one has done particularly well, scoring higher than 97% of its contemporaries.
We're also able to compare this research output to 4 others from the same source and published within six weeks on either side of this one. This one has scored higher than all of them